BENDER LEWIS H 4

What Happened
Lewis H. Bender, President & CEO and a director of Intensity Therapeutics (INTS), was granted 37,749 shares on 2026-03-26 as a fully vested stock award (reported as an acquisition) at an attributable price of $6.11 per share, for a total value of $230,646. The award was granted under the company's 2021 Stock Incentive Plan in partial satisfaction of his 2025 bonus, given at his request.

Key Details

• Transaction date and price: 2026-03-26; 37,749 shares at $6.11/share; total value $230,646. (Transaction code: A = Award/Grant)
• Shares owned after transaction: Not specified in this Form 4.
• Footnotes:
  • F1 — Award was fully vested and granted in partial satisfaction of the 2025 bonus in lieu of cash, at the reporting person's request.
  • F2 — All reported amounts have been adjusted for a 1-for-25 reverse stock split effective 2026-02-18; outstanding equity awards were proportionately adjusted.
• Filing timeliness: Form 4 filed 2026-03-30 reporting the 2026-03-26 transaction; filed within the required two business days.

Context
This was a compensation-related stock award (not an open-market purchase or sale). Fully vested awards increase the insider’s ownership immediately and are commonly used to satisfy bonuses or other pay obligations; they do not necessarily indicate a separate, discretionary market purchase or change in sentiment.